Related Experiment Video
Updated: Jan 5, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Catecholamine-induced reverse takotsubo cardiomyopathy.
Shivani Bhat1, Hashim Gazi2, Victor Mwansa2
1Graduate Entry Medical School, University of LimerickLimerickIreland.
Reverse takotsubo cardiomyopathy, a rare variant, occurred in a young man after an epinephrine overdose. This case highlights an unusual presentation of stress-induced cardiomyopathy.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Takotsubo cardiomyopathy (TTC) is a transient heart condition mimicking myocardial infarction.
- It typically affects postmenopausal women and is triggered by stress.
- Obstructive coronary artery disease is absent in TTC.
Observation:
- A young male patient presented with anaphylaxis and angioedema.
- He received an iatrogenic overdose of epinephrine for treatment.
- The patient subsequently developed reverse takotsubo cardiomyopathy with apical sparing.
Findings:
- The case demonstrates reverse takotsubo cardiomyopathy, a variant with basal hyperkinesis and apical hypokinesis.
- Apical sparing was noted in the patient's cardiac imaging.
- Epinephrine overdose was identified as the causative factor.
Implications:
- This case expands the understanding of takotsubo cardiomyopathy triggers beyond emotional or physical stress.
- It highlights the potential for iatrogenic causes, such as medication overdose, to induce cardiac dysfunction.
- Clinicians should consider drug-induced cardiomyopathy in the differential diagnosis of patients presenting with acute cardiac symptoms, especially after medication administration.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

